The U.S. Meals and Drug Administration (FDA) has upgraded a recall of a generally prescribed thyroid medicine on account of what it described as “subpotent” energetic components.
The recall of greater than 160,000 bottles of levothyroxine sodium, which went into impact June 20, was upgraded to a Class II recall on July 23. Class II remembers happen when use of the drug poses a average public well being danger, in response to the FDA.
The recall was initiated as a result of the medicine content material of the recalled tablets is “below the approved specification,” in response to the New York-based tv community NTD.
No different particulars had been obtainable concerning the recall, together with whether or not anybody has grow to be unwell from the weak tablets.
Levothyroxine sodium is used to deal with a sluggish thyroid gland (hypothyroidism). Left untreated, hypothyroidism can result in coronary heart issues and excessive ldl cholesterol, amongst different points, in response to the Mayo Clinic..
The recalled medicine are manufactured by India-based Intas Prescription drugs for North Carolina-based Accord Healthcare, NTD reported. They complete 160,630 bottles and are available numerous doses, strengths, and packages, together with:
Lot D2400536; expiration date, Feb. 28, 2026
Lot D2300325; expiration date, Jan. 31, 2026
Lot D2400679; expiration date, Feb. 28, 2026
Lot D2300087; expiration date, Dec. 31, 2025
Lot D2300092; expiration date, Dec. 31, 2025
Lot D2400722; expiration date, March 31, 2026
Lot D2300104; expiration date, Dec. 31, 2025
Lot D2300076; expiration date, Dec. 31, 2025
Lot D2300042; expiration date, Dec. 31, 2025
Extra info:
Extra particulars on the recalled thyroid tablets will be discovered on the FDA’s web site.
Quotation:
FDA upgrades recall on 160,000+ bottles of thyroid medicine (2025, July 24)
retrieved 24 July 2025
from https://medicalxpress.com/information/2025-07-fda-recall-bottles-thyroid-medication.html
This doc is topic to copyright. Aside from any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.
